| Product Code: ETC8543280 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Netherlands Motor Neurone Disease (MND) Market Overview |
3.1 Netherlands Country Macro Economic Indicators |
3.2 Netherlands Motor Neurone Disease (MND) Market Revenues & Volume, 2021 & 2031F |
3.3 Netherlands Motor Neurone Disease (MND) Market - Industry Life Cycle |
3.4 Netherlands Motor Neurone Disease (MND) Market - Porter's Five Forces |
3.5 Netherlands Motor Neurone Disease (MND) Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Netherlands Motor Neurone Disease (MND) Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 Netherlands Motor Neurone Disease (MND) Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.8 Netherlands Motor Neurone Disease (MND) Market Revenues & Volume Share, By Dosage, 2021 & 2031F |
3.9 Netherlands Motor Neurone Disease (MND) Market Revenues & Volume Share, By End users, 2021 & 2031F |
4 Netherlands Motor Neurone Disease (MND) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and diagnosis rates of motor neurone disease (MND) in the Netherlands |
4.2.2 Advances in medical research leading to the development of new treatments and therapies for MND |
4.2.3 Growing healthcare expenditure and investment in neurodegenerative diseases in the Netherlands |
4.3 Market Restraints |
4.3.1 Limited availability and accessibility of specialized care and support services for MND patients in the Netherlands |
4.3.2 High cost associated with MND treatments and therapies leading to financial burden on patients and healthcare systems |
5 Netherlands Motor Neurone Disease (MND) Market Trends |
6 Netherlands Motor Neurone Disease (MND) Market, By Types |
6.1 Netherlands Motor Neurone Disease (MND) Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Netherlands Motor Neurone Disease (MND) Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Netherlands Motor Neurone Disease (MND) Market Revenues & Volume, By Amyotrophic lateral sclerosis (ALS), 2021- 2031F |
6.1.4 Netherlands Motor Neurone Disease (MND) Market Revenues & Volume, By Progressive bulbar palsy (PBP), 2021- 2031F |
6.1.5 Netherlands Motor Neurone Disease (MND) Market Revenues & Volume, By Progressive muscular atrophy (PMA), 2021- 2031F |
6.1.6 Netherlands Motor Neurone Disease (MND) Market Revenues & Volume, By Primary lateral sclerosis (PLS), 2021- 2031F |
6.2 Netherlands Motor Neurone Disease (MND) Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 Netherlands Motor Neurone Disease (MND) Market Revenues & Volume, By Medication, 2021- 2031F |
6.2.3 Netherlands Motor Neurone Disease (MND) Market Revenues & Volume, By Physiotherapy, 2021- 2031F |
6.2.4 Netherlands Motor Neurone Disease (MND) Market Revenues & Volume, By Palliative Care, 2021- 2031F |
6.2.5 Netherlands Motor Neurone Disease (MND) Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Netherlands Motor Neurone Disease (MND) Market, By Diagnosis |
6.3.1 Overview and Analysis |
6.3.2 Netherlands Motor Neurone Disease (MND) Market Revenues & Volume, By Blood test, 2021- 2031F |
6.3.3 Netherlands Motor Neurone Disease (MND) Market Revenues & Volume, By Electromyography (EMG), 2021- 2031F |
6.3.4 Netherlands Motor Neurone Disease (MND) Market Revenues & Volume, By MRI Scan, 2021- 2031F |
6.3.5 Netherlands Motor Neurone Disease (MND) Market Revenues & Volume, By Transcranial magnetic stimulation (TMS), 2021- 2031F |
6.3.6 Netherlands Motor Neurone Disease (MND) Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Netherlands Motor Neurone Disease (MND) Market, By Dosage |
6.4.1 Overview and Analysis |
6.4.2 Netherlands Motor Neurone Disease (MND) Market Revenues & Volume, By Tablet, 2021- 2031F |
6.4.3 Netherlands Motor Neurone Disease (MND) Market Revenues & Volume, By Injection, 2021- 2031F |
6.4.4 Netherlands Motor Neurone Disease (MND) Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Netherlands Motor Neurone Disease (MND) Market, By End users |
6.5.1 Overview and Analysis |
6.5.2 Netherlands Motor Neurone Disease (MND) Market Revenues & Volume, By Clinic, 2021- 2031F |
6.5.3 Netherlands Motor Neurone Disease (MND) Market Revenues & Volume, By Hospital, 2021- 2031F |
6.5.4 Netherlands Motor Neurone Disease (MND) Market Revenues & Volume, By Others, 2021- 2031F |
7 Netherlands Motor Neurone Disease (MND) Market Import-Export Trade Statistics |
7.1 Netherlands Motor Neurone Disease (MND) Market Export to Major Countries |
7.2 Netherlands Motor Neurone Disease (MND) Market Imports from Major Countries |
8 Netherlands Motor Neurone Disease (MND) Market Key Performance Indicators |
8.1 Average time from symptom onset to diagnosis for MND patients in the Netherlands |
8.2 Number of clinical trials and research studies focused on MND in the Netherlands |
8.3 Percentage of MND patients receiving multidisciplinary care and support services in the Netherlands |
9 Netherlands Motor Neurone Disease (MND) Market - Opportunity Assessment |
9.1 Netherlands Motor Neurone Disease (MND) Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Netherlands Motor Neurone Disease (MND) Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 Netherlands Motor Neurone Disease (MND) Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.4 Netherlands Motor Neurone Disease (MND) Market Opportunity Assessment, By Dosage, 2021 & 2031F |
9.5 Netherlands Motor Neurone Disease (MND) Market Opportunity Assessment, By End users, 2021 & 2031F |
10 Netherlands Motor Neurone Disease (MND) Market - Competitive Landscape |
10.1 Netherlands Motor Neurone Disease (MND) Market Revenue Share, By Companies, 2024 |
10.2 Netherlands Motor Neurone Disease (MND) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here